Gazala Bashir
Lifestyle modifications have led to a widespread prevalence of chronic illnesses, posing significant challenges to public health and global economic stability. Key risk factors contributing to these conditions comprise abdominal obesity, insulin resistance, hypertension, dyslipidemia, heightened triglyceride levels, cancer, and related attributes. In recent years, there has been increasing interest in utilizing plant-based proteins for managing and preventing chronic diseases. Soybean, a cost-effective protein source containing approximately 40% protein, has garnered significant attention. Soybean peptides have been extensively investigated for their role in regulating chronic diseases. This review provides a concise overview of the structure, function, absorption, and metabolism of soybean peptides. Furthermore, it examines the regulatory effects of soybean peptides on key chronic diseases such as obesity, diabetes mellitus, Cardiovascular Diseases (CVD), and cancer. The review also discusses the limitations of existing functional research on soybean proteins and peptides in addressing chronic diseases, along with potential future research directions.
Share this article